PEDIATRICS Vol. 21 No. 2 February 1958, pp. 267-278
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Husson, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Husson, G. S.

THE PLACE OF METHACHOLINE (MECHOLYL®) IN THE MANAGEMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

George S. Husson M.D.1

1 Department of Pediatrics, State University of New York, College of Medicine at Syracuse

Methacholine has a distinct place in the management of paroxysmal supraventricular tachycardia.

It is recommended as the drug of choice when a patient is moribund and a fastacting drug is indicated.

Certain indispensable precautions are outlined for its use.

The interaction of methacholine and popularly used drugs such as quinidine and digitalis is discussed.

The observations on an infant with recurrent supraventricular tachycardia, successfully treated with methacholine on several occasions, are presented.

Submitted on May 17, 1957
Accepted on August 30, 1957